Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients.

Massip C, Mathieu C, Gaudru C, Miaut V, Floch P, Oswald E, Segonds C, Guet-Revillet H.

J Antimicrob Chemother. 2019 Feb 1;74(2):525-528. doi: 10.1093/jac/dky423. No abstract available.

PMID:
30312409
2.

Epidemic spread of Pandoraea pulmonicola in a cystic fibrosis center.

Degand N, Lotte R, Decondé Le Butor C, Segonds C, Thouverez M, Ferroni A, Vallier C, Mély L, Carrère J.

BMC Infect Dis. 2015 Dec 26;15:583. doi: 10.1186/s12879-015-1327-8.

3.

Bacterial colonization status of cystic fibrosis children's toothbrushes: A pilot study.

Genevois A, Roques C, Segonds C, Cavalié L, Brémont F, Maubisson L, Mas E, Mittaine M.

Arch Pediatr. 2015 Dec;22(12):1240-6. doi: 10.1016/j.arcped.2015.09.023. Epub 2015 Nov 17.

PMID:
26596857
4.

Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network.

Kempf M, Varon E, Lepoutre A, Gravet A, Baraduc R, Brun M, Chardon H, Cremniter J, Croizé J, Dalmay F, Demachy MC, Fosse T, Grelaud C, Hadou T, Hamdad F, Koeck JL, Luce S, Mermond S, Patry I, Péchinot A, Raymond J, Ros A, Segonds C, Soullié B, Tandé D, Vergnaud M, Vernet-Garnier V, Wallet F, Gutmann L, Ploy MC, Lanotte P.

Clin Microbiol Infect. 2015 Jan;21(1):35-42. doi: 10.1016/j.cmi.2014.08.009. Epub 2014 Oct 12.

5.

Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of Burkholderia cenocepacia and application to nationwide epidemiological analysis.

Segonds C, Thouverez M, Barthe A, Bossuet-Greif N, Tisseyre L, Plésiat P, Vergnaud G, Chabanon G, Pourcel C.

J Clin Microbiol. 2015 Feb;53(2):398-409. doi: 10.1128/JCM.02473-14. Epub 2014 Nov 19.

6.

A French multicentric study and review of pulmonary Nocardia spp. in cystic fibrosis patients.

Rodriguez-Nava V, Durupt S, Chyderiotis S, Freydière AM, Karsenty J, de Montclos M, Reix P, Durieu I, Nove-Josserand R, Chiron R, Bremont F, Têtu L, Murris M, Terru D, Godreuil S, Bergeron E, Freney J, Boiron P, Vandenesch F, Marchandin H, Segonds C, Doléans-Jordheim A.

Med Microbiol Immunol. 2015 Aug;204(4):493-504. doi: 10.1007/s00430-014-0360-3. Epub 2014 Oct 26.

PMID:
25344657
7.

Successful outbreak investigation of Burkholderia cepacia complex bacteremia in intensive care patients.

Wiener-Well Y, Segonds C, Mazuz B, Kopuit P, Assous MV.

Am J Infect Control. 2014 May;42(5):580-1. doi: 10.1016/j.ajic.2013.12.015. Epub 2014 Mar 19. No abstract available.

PMID:
24655899
8.

Aspergillus sensitization or carriage in cystic fibrosis patients.

Fillaux J, Brémont F, Murris M, Cassaing S, Tétu L, Segonds C, Pipy B, Magnaval JF.

Pediatr Infect Dis J. 2014 Jul;33(7):680-6. doi: 10.1097/INF.0000000000000231.

PMID:
24336095
9.
10.

Bronchial colonisation in patients with lung cancer: a prospective study.

Laroumagne S, Lepage B, Hermant C, Plat G, Phelippeau M, Bigay-Game L, Lozano S, Guibert N, Segonds C, Mallard V, Augustin N, Didier A, Mazieres J.

Eur Respir J. 2013 Jul;42(1):220-9. doi: 10.1183/09031936.00062212. Epub 2012 Oct 25.

11.

Identification of cause of posttransplant cachexia by PCR.

Guitard J, Edouard S, Lepidi H, Segonds C, Grare M, Ranty-Quintyn ML, Rouquette I, Cointault O, Rostaing L, Kamar N, Fenollar F.

Emerg Infect Dis. 2012 Aug;18(8):1386-8. doi: 10.3201/eid1808.120309. No abstract available.

12.

Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients.

Fillaux J, Brémont F, Murris M, Cassaing S, Rittié JL, Tétu L, Segonds C, Abbal M, Bieth E, Berry A, Pipy B, Magnaval JF.

Scand J Infect Dis. 2012 Nov;44(11):842-7. doi: 10.3109/00365548.2012.695454. Epub 2012 Jul 25.

PMID:
22831545
13.

Performances of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for rapid identification of bacteria in routine clinical microbiology.

Dubois D, Grare M, Prere MF, Segonds C, Marty N, Oswald E.

J Clin Microbiol. 2012 Aug;50(8):2568-76. doi: 10.1128/JCM.00343-12. Epub 2012 May 16.

14.

Identification of Stenotrophomonas maltophilia strains isolated from environmental and clinical samples: a rapid and efficient procedure.

Pinot C, Deredjian A, Nazaret S, Brothier E, Cournoyer B, Segonds C, Favre-Bonté S.

J Appl Microbiol. 2011 Nov;111(5):1185-93. doi: 10.1111/j.1365-2672.2011.05120.x. Epub 2011 Aug 30.

15.

A novel highly charged exopolysaccharide produced by two strains of Stenotrophomonas maltophilia recovered from patients with cystic fibrosis.

Cescutti P, Cuzzi B, Liut G, Segonds C, Di Bonaventura G, Rizzo R.

Carbohydr Res. 2011 Sep 27;346(13):1916-23. doi: 10.1016/j.carres.2011.05.007. Epub 2011 May 13.

PMID:
21636078
16.

[Incidence and characteristics of bronchial colonisation in patient with lung cancer: a retrospective study of 388 cases].

Laroumagne S, Salinas-Pineda A, Hermant C, Murris M, Gourraud PA, Do C, Segonds C, Didier A, Mazières J.

Rev Mal Respir. 2011 Mar;28(3):328-35. doi: 10.1016/j.rmr.2010.05.020. Epub 2011 Feb 3. French.

PMID:
21482336
17.

Multilocus sequence-based analysis delineates a clonal population of Agrobacterium (Rhizobium) radiobacter (Agrobacterium tumefaciens) of human origin.

Aujoulat F, Jumas-Bilak E, Masnou A, Sallé F, Faure D, Segonds C, Marchandin H, Teyssier C.

J Bacteriol. 2011 May;193(10):2608-18. doi: 10.1128/JB.00107-11. Epub 2011 Mar 11.

18.

Epidemiology and antimicrobial resistance of Streptococcus pneumoniae in France in 2007: data from the pneumococcus surveillance network.

Kempf M, Baraduc R, Bonnabau H, Brun M, Chabanon G, Chardon H, Croizé J, Demachy MC, Donnio PY, Dupont P, Fosse T, Gibel L, Gravet A, Grignon B, Hadou T, Hamdad F, Joly-Guillou ML, Koeck JL, Maugein J, Péchinot A, Ploy MC, Raymond J, Ros A, Roussel-Delvallez M, Segonds C, Vergnaud M, Vernet-Garnier V, Lepoutre A, Gutmann L, Varon E, Lanotte P.

Microb Drug Resist. 2011 Mar;17(1):31-6. doi: 10.1089/mdr.2010.0031. Epub 2010 Sep 1.

PMID:
20809835
19.

[Fulminant pneumococcemia: bacteria and complement partners in crime].

Ruiz S, Segonds C, Georges B, Puissant B, Ponard D, Fourcade O, Conil JM.

Ann Fr Anesth Reanim. 2010 Jul-Aug;29(7-8):593-4. doi: 10.1016/j.annfar.2010.05.013. Epub 2010 Jul 2. French. No abstract available.

PMID:
20598496
20.

[Assessment of the contribution of the immunochromatographic pneumococcal urinary antigen test to the etiological diagnosis of pneumonia in hospitalized adults].

Segonds C, Le Goff A, Chabanon G.

Pathol Biol (Paris). 2010 Apr;58(2):117-22. doi: 10.1016/j.patbio.2009.07.037. Epub 2009 Oct 28. French.

PMID:
19875240
21.

Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.

Segonds C, Clavel-Batut P, Thouverez M, Grenet D, Le Coustumier A, Plésiat P, Chabanon G.

J Clin Microbiol. 2009 May;47(5):1510-6. doi: 10.1128/JCM.02489-08. Epub 2009 Mar 18.

22.

Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients.

Degand N, Carbonnelle E, Dauphin B, Beretti JL, Le Bourgeois M, Sermet-Gaudelus I, Segonds C, Berche P, Nassif X, Ferroni A.

J Clin Microbiol. 2008 Oct;46(10):3361-7. doi: 10.1128/JCM.00569-08. Epub 2008 Aug 6.

23.

Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis.

Zebouh M, Thomas C, Honderlick P, Lemee L, Segonds C, Wallet F, Husson MO.

J Cyst Fibros. 2008 May;7(3):238-43. doi: 10.1016/j.jcf.2007.10.002. Epub 2008 Feb 20.

24.

Selection of nitrogen-fixing deficient Burkholderia vietnamiensis strains by cystic fibrosis patients: involvement of nif gene deletions and auxotrophic mutations.

Menard A, Monnez C, Estrada de Los Santos P, Segonds C, Caballero-Mellado J, Lipuma JJ, Chabanon G, Cournoyer B.

Environ Microbiol. 2007 May;9(5):1176-85.

25.

Increased amikacin dosage requirements in burn patients receiving a once-daily regimen.

Conil JM, Georges B, Breden A, Segonds C, Lavit M, Seguin T, Coley N, Samii K, Chabanon G, Houin G, Saivin S.

Int J Antimicrob Agents. 2006 Sep;28(3):226-30. Epub 2006 Aug 14.

PMID:
16908121
26.

[Evaluation of a new E-test method for antimicrobial sensitivity testing of Pseudomonas aeruginosa isolates from cystic fibrosis].

Zebouh M, Thomas C, Honderlick P, Lemee L, Segonds C, Wallet F, Husson MO.

Pathol Biol (Paris). 2005 Oct-Nov;53(8-9):490-4. Epub 2005 Aug 8. French.

PMID:
16087300
27.

Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis.

Chiron R, Marchandin H, Counil F, Jumas-Bilak E, Freydière AM, Bellon G, Husson MO, Turck D, Brémont F, Chabanon G, Segonds C.

J Clin Microbiol. 2005 Aug;43(8):3938-43.

28.

Epidemiological investigation of a Serratia liquefaciens outbreak in a neurosurgery department.

Dubouix A, Roques C, Segonds C, Jeannot MJ, Malavaud S, Daude S, Chabanon G, Marty N.

J Hosp Infect. 2005 May;60(1):8-13.

PMID:
15823650
29.

OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Poirel L, Marqué S, Héritier C, Segonds C, Chabanon G, Nordmann P.

Antimicrob Agents Chemother. 2005 Jan;49(1):202-8.

30.

[What microbiological criteria define a colonization or infection with Staphylococcus aureus?].

Chabanon G, Segonds C.

Rev Mal Respir. 2003 Apr;20(2 Pt 2):S79-83. Review. French. No abstract available.

PMID:
12910138
32.

[Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis].

Segonds C, Chabanon G.

Ann Biol Clin (Paris). 2001 May-Jun;59(3):259-69. Review. French.

33.

Exopolysaccharide production by mucoid and non-mucoid strains of Burkholderia cepacia.

Cérantola S, Bounéry J, Segonds C, Marty N, Montrozier H.

FEMS Microbiol Lett. 2000 Apr 15;185(2):243-6.

34.
36.

Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.

van Pelt C, Verduin CM, Goessens WH, Vos MC, Tümmler B, Segonds C, Reubsaet F, Verbrugh H, van Belkum A.

J Clin Microbiol. 1999 Jul;37(7):2158-64.

37.

Evaluation of the Vega haematology analyser in a university hospital setting.

Corberand JX, Segonds C, Fontanilles AM, Cambus JP, Fillola G, Laharrague P.

Clin Lab Haematol. 1999 Feb;21(1):3-10.

PMID:
10197256
38.

Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire.

Garand R, Goasguen J, Brizard A, Buisine J, Charpentier A, Claisse JF, Duchayne E, Lagrange M, Segonds C, Troussard X, Flandrin G.

Br J Haematol. 1998 Nov;103(2):488-94.

PMID:
9827924
39.

Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers.

Segonds C, Bingen E, Couetdic G, Mathy S, Brahimi N, Marty N, Plesiat P, Michel-Briand Y, Chabanon G.

J Clin Microbiol. 1997 Aug;35(8):2055-60.

40.

Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. The French Observatoire Burkholderia cepacia Study Group.

Segonds C, Chabanon G, Couetdic G, Michel-Briand Y, Bingen E.

Eur J Clin Microbiol Infect Dis. 1996 Oct;15(10):841-2. No abstract available.

PMID:
8950569
41.

[Mycoplasmas and pregnancy. Preliminary study].

Segonds C, Francoual D, Assemekang B, Ioan A.

J Gynecol Obstet Biol Reprod (Paris). 1992;21(4):385-92. French.

PMID:
1624724

Supplemental Content

Loading ...
Support Center